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Background: Fournier’s gangrene in the setting of rectal cancer is rare. Treatment for Fournier’s gangrene
associated with rectal cancer is more complex than other cases of Fournier’s gangrene. We report on a patient
with severe Fournier’s gangrene in the setting of locally advanced rectal cancer who was treated with a
combined modality therapy.
Case presentation: A 65-year-old man presented with general fatigue and anal pain. The medical and surgical
histories were unremarkable. A black spot on the perineal skin surrounded by erythema was found on physical
examination, suspicious for Fournier’s gangrene. Computed tomography scan showed a rectal tumor invading
into the bladder (clinically T4bN2M0) and abscess formation with emphysema around the rectum. He was thus
diagnosed with locally advanced rectal cancer and Fournier’s gangrene with a severity index score of 12 points.
We created a diverting loop colostomy of the transverse colon and performed extensive debridement of the
perineum and perianal area. Fifty days later, the patient underwent radical total pelvic exenteration with sacrectomy. In
addition, reconstruction of the soft tissue defect was performed using the rectus muscle, the gluteus maximus muscle,
and the femoral muscle. Histopathological findings of the specimen were as follows: the tumor was a moderately
adenocarcinoma with invasion to the bladder and the prostate (T4b), metastases to four resected lymph nodes (N2),
and lymphovascular invasion. There were no major postoperative complications, and the patient was discharged
108 days postoperatively.
Conclusions: We report a rare case of locally invasive rectal cancer associated with Fournier’s gangrene. This case
highlights a usual cause of Fournier’s gangrene. Physicians should be cognizant not only of the more common
condition but also of the rare presentations including those associated with rectal cancer.
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APR, Abdominoperineal resection; FGSI, Fournier’s gangrene severity indexBackground
Fournier’s gangrene (FG) is necrotizing fasciitis and
commonly begins without trauma or urinary tract dis-
ease. FG in the setting of rectal cancer is rare. A specific
risk factor is rectal cancer perforation. Treatment in-
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Fig. 1 The appearance of the patient’s perineum. A black spot and
emphysema were found in the perineal skin
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A 65-year-old man was brought to our outpatient hos-
pital in an ambulance complaining of general fatigue
and anal pain. The medical and surgical histories were
unremarkable. His initial body temperature was 95.7 °F,
blood pressure was 125/58 mmHg, heart rate was 92
beats/min, and oxygen saturation was 98 % on room air.
On physical examination, a black spot on the perineal
skin surrounded by erythema was found. Due to a clin-
ical suspicion for FG, a computed tomography (CT) scan
and blood tests were obtained urgently (Fig. 1). CT scan
showed abscess formation with emphysema around the
rectum, as well as a tumor invading the bladder (cT4b)
with some lymph node metastases in the mesorectum
(cN2); there was no evidence of distant metastasis (M0)
(Fig. 2). Blood tests were remarkable for a hemoglobin
of 3.2 g/dl and a leukocytosis of 63,200/μl. The patient
was thus diagnosed with locally advanced rectal cancer
and FG with a severity index score of 12 points [1]. Urgent
diverting colostomy of the transverse colon and extensive
debridement of the perineal area were performed (Fig. 3).
Biopsies taken previously revealed a moderately differenti-
ated adenocarcinoma.
The patient received nutritional support after surgery.
Follow-up CT scan after the surgery showed no newFig. 2 Computed tomography scan showing a rectal tumor invading the b
perineum (b)lesions, so we performed a radical total pelvic exenter-
ation (TPE) with sacrectomy 50 days after the initial
surgery. For the urinary diversion, Bricker’s operation
was performed (Fig. 4). In addition, reconstruction of
the soft tissue defect was performed using the rectus
muscle, the gluteus maximus muscle, and the femoral
muscle (Fig. 5). Histopathological findings of the specimen
were as follows: the tumor was a moderate adenocarcin-
oma with invasion to the bladder and the prostate (T4b),
metastases to four resected lymph nodes (N2), and lym-
phovascular invasion. There were no major postopera-
tive complications, and the patient was discharged on
postoperative day 108.
Discussion
Although perforation of rectal cancer after treatment
with bevacizumab or radiation therapy has been well
documented, reports of spontaneous perforation of rectal
cancer presenting as FG are rare. There were 23 cases
evaluated in a review by Bruketa et al. [2]; in Japan, 17
cases including the present case have been reported
(Table 1). The median age in the Japanese group was 58
(range, 30–80) years with a male to female ratio of 15:2.
Six (35 %) of 17 patients had diabetes mellitus (DM) as a
comorbidity. DM was considered a risk factor for FG in
the Japanese group as well. Colostomy was created in 9 of
17 patients. Treatment for rectal cancer with FG was
abdominoperineal resection (APR) for six patients, TPE
for three patients, and chemotherapy alone for three pa-
tients. Four patients were followed conservatively without
treatment. Regarding long-term prognosis of the patients,
survival of 4 years and 7 months was obtained in one pa-
tient who underwent APR, and the survival of the other
16 patients was not given. In this patient, we performed
TPE with sacrectomy to obtain a negative resection mar-
gin, resulting in a good oncological outcome. In addition,
reconstruction was performed using the rectus muscle,
the gluteus maximus muscles, and the femoral muscle.
There were no major postoperative complications, and
the patient was discharged on postoperative day 108.
The mortality of FG is high, frequently due to a delay
in the diagnosis and management. The interesting reportladder (a) and abscess formation with emphysema in the pelvis and
Fig. 3 Extensive debridement and diverting colostomy were
performed on the day of admission (a). Fifty days later, a more
extensive debridement was performed (b)
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by Surucu et al. [3]. They showed the significance of
18F-fluorodeoxyglucose positron emission tomography for
FG in metabolic levels before the visual changes occurred.
The mortality of FG in the setting of rectal cancer is notFig. 4 TPE with sacrectomy was performed to obtain a negative
resection margin. Histopathological findings of the specimen
revealed a moderate adenocarcinoma invading into the bladder and
the prostate (T4b), metastasis to four perirectal lymph nodes (N2),
and lymphovascular invasion
Fig. 5 Reconstruction was performed using the rectus muscle, the
gluteus maximus muscle, and the femoral muscleclear. The most common causes of death in FG are sepsis
and multiple organ failure. Prognostic predictions can be
based on Fournier’s gangrene severity index (FGSI), com-
prised of the following: body temperature, heart rate, re-
spiratory rate, and serum level of sodium, potassium,
creatinine, and bicarbonate, as well as hematocrit value
and leukocyte count [1]. Laor et al. [1] stated that a score
of >9 was associated with a 75 % mortality, while a score
Table 1 Case reports of Fournier’s gangrene in the setting of rectal cancer in Japan
No. Author Gender Age Location Comorbidity Operation Outcome
1 Futamura et al. [6] 1995 M 56 Rb None APR 4 years and 7 months, alive
2 Fujisawa et al. [7] 1999 M 75 Rb None None Death at 6 days
3 Nakao et al. [8] 1999 M 51 Rb DM None Unknown
4 Saito et al. [9] 2000 M 60 Rb None TPE 1 year, alive
5 Noriyuki et al. [10] 2003 M 58 Ra DM 5-FU + LV 1 year and 2 months, alive
6 Enomoto at al. [11] 2006 M 35 Rb None APR 3 months, alive
7 Moriwaki et al. [12] 2007 M 30 Rb-P Unknown APR Death at 11 months
8 Kojima et al. [13] 2007 M 56 Rb DM TPE 4 months, alive
9 Morohashi et al. [14] 2008 M 60 Rb DM None Death at 2 months
10 Ishibashi et al. [15] 2009 F 80 Rb HT APR 2 months, alive
11 Yamazaki et al. [16] 2010 M 50s Rb DM APR 1 months, alive
12 Onizuka et al. [17] 2010 M 55 Rs None Chemo 1 year and 2 months, alive
13 Tanaka et al. [18] 2010 F 52 Rb DM APR 5 months, alive
14 Watabe et al. [19] 2013 M 77 Rb-P Unknown None 2 months, alive
15 Monma et al. [20] 2013 M 79 P HT CRT 1 year, alive
16 Kawagoe et al. [21] 2014 M 72 Rb None FOLFOX + bev 6 months, alive
17 Our case 2016 M 65 Rb None TPE Death at 1 year
M male, F female, Rb lower rectum, Rs rectosigmoid colon, P proctos, APR abdominoperineal resection, TPE total pelvic exenteration, Chemo chemotherapy, CRT
chemoradiation therapy, Bev bevacizumab, DM diabetes mellitus, HT hypertension
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While our patient presented with an FGSI score of 12
points, we managed to treat the patient without a major
complication. Recently, hyperbaric oxygen (HBO) has
been recommended as an additional therapy for patients
with FG because HBO inhibits the growth of anaerobic
bacteria in the affected tissues, prevents further extension
of tissue necrosis, and reduces systemic toxicity [4, 5].
Actually, for this patient creating colostomy as an initial
procedure, early radical debridement of necrotic tis-
sues, drainage, and antibiotic therapy were effective to
manage severe FG in the setting of rectal cancer. Al-
though TPE with sacrectomy was required to obtain a
negative resection margin, we could get a good out-
come. Although adjuvant therapy was required because
of locally advanced rectal cancer of pathologically T4bFig. 6 18F-fluorodeoxyglucose positron emission tomography scan demon
wound. The maximum standardized uptake values (SUV max) of the lesion
because of an abnormal 18F-fluorodeoxyglucose positron emission tomogrN2 M0, the patient was followed up at the outpatient
section of our institution without adjuvant therapy until
all wound had healed completely. Unfortunately, we sus-
pected that local recurrence developed in the perineal
wound because of an abdominal 18F-fluorodeoxyglucose
positron emission tomography in 5 months after curative
TPE (Fig. 6). The patient died of primary disease 1 year
after prior surgery.
Conclusions
Aggressive debridement, broad-spectrum antibiotics, and
intensive supportive care are critical for the management
of FG. Although colorectal cancer has previously been re-
ported as a cause of FG, it remains an extremely rare
phenomenon.strated increased fluorodeoxyglucose uptake lesions in the perineal
s were 6.36 and 13.45, respectively. Local recurrence was suspected
aphy scan
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